Back


15/11/2016
Kurma Partners and Idinvest Partners launches Dynacure a new company specialized in rare neuromuscular diseases
Kurma announced on Monday the 24th of October 2016, that they have entered into a collaboration agreement with Conectus and Ionis Pharmaceutical to launch Dynacure, a Strasbourg-based biotech specializing in the treatment of rare neuromuscular disorders. [...]

Download the pdf file





X

X